We are mission-focused on developingone-time treatments for genetic disorders We are partners to the rare disease community Learn about our Clinical Trials >>> We Are Applying our Broad Genetic Medicines Platform to Treat, or Cure, Genetic Disease Learn About Our Platform >>> View Our Pipeline >>> Recent News >>> January 4, 2023Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials and Announces Expected 2023 Milestones, Including Initial Data Read-Outs from Both ProgramsNovember 10, 2022Homology Medicines Reports Third Quarter 2022 Financial Results and Recent HighlightsOctober 27, 2022Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting We are Homology Learn about our Team and Mission >>>
